NSD1
Basic information
Region (hg38): 5:177131830-177300213
Previous symbols: [ "STO" ]
Links
Phenotypes
GenCC
Source:
- Sotos syndrome (Definitive), mode of inheritance: AD
- Sotos syndrome 1 (Strong), mode of inheritance: AD
- Sotos syndrome 1 (Strong), mode of inheritance: AD
- Sotos syndrome 1 (Definitive), mode of inheritance: AD
- Sotos syndrome (Supportive), mode of inheritance: AD
- Sotos syndrome (Definitive), mode of inheritance: AD
- Beckwith-Wiedemann syndrome due to NSD1 mutation (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Sotos syndrome 1; Weaver syndrome; Beckwith-Wiedemann syndrome | AD | Cardiovascular; Oncologic; Renal | While only reported in the minority of individuals, individuals are at increased risk of malignancy, and recognition may allow prompt diagnosis and treatment; Surveillance for cardiac and renal complications may also be beneficial in order to allow prompt recognition and management | Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal | 14148233; 4366187; 6324572; 3565472; 2319581; 1552397; 10507738; 10434127; 11146472; 11078573; 11813184; 11896389; 12464997; 12525543; 14517949; 14571271; 14997421; 15125616; 16010674; 15452385; 15362962; 15455365; 15365454; 16170239; 15942875; 15852475; 16222665; 16780628; 16329110; 17825104; 17480008; 17420391; 18304174; 19914434; 20101679; 20420030; 21677402; 21738022; 21834047; 22012791; 21342349; 20301652 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (1678 variants)
- Sotos_syndrome (851 variants)
- Inborn_genetic_diseases (378 variants)
- not_specified (152 variants)
- NSD1-related_disorder (110 variants)
- Beckwith-Wiedemann_syndrome (32 variants)
- Acute_myeloid_leukemia (8 variants)
- See_cases (8 variants)
- Intellectual_disability (6 variants)
- Weaver_syndrome (6 variants)
- Neurodevelopmental_disorder (4 variants)
- Neurodevelopmental_delay (2 variants)
- Hereditary_spastic_paraplegia_8 (1 variants)
- Abnormal_cerebral_morphology (1 variants)
- Microcephaly (1 variants)
- Delayed_speech_and_language_development (1 variants)
- Marfanoid_habitus_and_intellectual_disability (1 variants)
- Congenital_diaphragamitc_hernia (1 variants)
- Scoliosis (1 variants)
- Hypertelorism (1 variants)
- High_anterior_hairline (1 variants)
- Osteopenia (1 variants)
- Delayed_gross_motor_development (1 variants)
- Non-immune_hydrops_fetalis (1 variants)
- Pointed_chin (1 variants)
- Holoprosencephaly_2 (1 variants)
- Global_developmental_delay (1 variants)
- Tall_stature (1 variants)
- Overgrowth (1 variants)
- Choroid_plexus_carcinoma (1 variants)
- Hereditary_cancer (1 variants)
- High_forehead (1 variants)
- Hypoplasia_of_the_corpus_callosum (1 variants)
- Preeclampsia (1 variants)
- Macrocephaly (1 variants)
- Increased_body_weight (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NSD1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000022455.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 18 | 319 | 17 | 358 | ||
| missense | 57 | 129 | 783 | 333 | 38 | 1340 |
| nonsense | 131 | 18 | 152 | |||
| start loss | 0 | |||||
| frameshift | 256 | 51 | 11 | 319 | ||
| splice donor/acceptor (+/-2bp) | 31 | 22 | 55 | |||
| Total | 478 | 221 | 817 | 653 | 55 |
Highest pathogenic variant AF is 0.0000065720296
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| NSD1 | protein_coding | protein_coding | ENST00000439151 | 22 | 167191 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.00 | 7.31e-15 | 125741 | 0 | 7 | 125748 | 0.0000278 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 3.41 | 1065 | 1.43e+3 | 0.746 | 0.0000790 | 17650 |
| Missense in Polyphen | 179 | 418.12 | 0.42811 | 5206 | ||
| Synonymous | 0.0779 | 523 | 525 | 0.996 | 0.0000282 | 5309 |
| Loss of Function | 9.31 | 5 | 111 | 0.0452 | 0.00000678 | 1380 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000289 | 0.0000289 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.0000462 | 0.0000462 |
| European (Non-Finnish) | 0.0000441 | 0.0000439 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Histone methyltransferase. Preferentially methylates 'Lys-36' of histone H3 and 'Lys-20' of histone H4 (in vitro). Transcriptional intermediary factor capable of both negatively or positively influencing transcription, depending on the cellular context. {ECO:0000269|PubMed:21196496}.;
- Disease
- DISEASE: Beckwith-Wiedemann syndrome (BWS) [MIM:130650]: A disorder characterized by anterior abdominal wall defects including exomphalos (omphalocele), pre- and postnatal overgrowth, and macroglossia. Additional less frequent complications include specific developmental defects and a predisposition to embryonal tumors. {ECO:0000269|PubMed:14997421}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving NSD1 is found in childhood acute myeloid leukemia. Translocation t(5;11)(q35;p15.5) with NUP98.; DISEASE: Note=A chromosomal aberration involving NSD1 is found in an adult form of myelodysplastic syndrome (MDS). Insertion of NUP98 into NSD1 generates a NUP98-NSD1 fusion product. {ECO:0000269|PubMed:15382262}.;
- Pathway
- Lysine degradation - Homo sapiens (human);Histone Modifications;Pathways Affected in Adenoid Cystic Carcinoma;PKMTs methylate histone lysines;Chromatin modifying enzymes;AndrogenReceptor;Lysine metabolism;Chromatin organization
(Consensus)
Recessive Scores
- pRec
- 0.241
Intolerance Scores
- loftool
- 0.00186
- rvis_EVS
- -1.55
- rvis_percentile_EVS
- 3.24
Haploinsufficiency Scores
- pHI
- 0.661
- hipred
- N
- hipred_score
- 0.471
- ghis
- 0.580
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.959
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nsd1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;regulation of histone H3-K36 methylation;regulation of transcription, DNA-templated;histone H3-K36 methylation;histone methylation;regulation of peptidyl-serine phosphorylation;histone H4-K20 methylation;positive regulation of transcription, DNA-templated;regulation of RNA polymerase II regulatory region sequence-specific DNA binding
- Cellular component
- chromatin;nucleus;nucleoplasm;chromosome
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;chromatin binding;transcription coregulator activity;transcription corepressor activity;protein binding;zinc ion binding;histone-lysine N-methyltransferase activity;estrogen receptor binding;histone methyltransferase activity (H4-K20 specific);retinoic acid receptor binding;retinoid X receptor binding;thyroid hormone receptor binding;histone methyltransferase activity (H3-K36 specific);androgen receptor binding